浏览全部资源
扫码关注微信
AKT1介导的肝癌细胞自噬增强125I粒籽辐照敏感性
AKT1-mediated autophagy of hepatocellular carcinoma cells enhances cell sensitivity to 125I seed irradiation
- 陆军军医大学学报 2025年47卷第6期 页码：539-550
- 作者机构：
陆军军医大学（第三军医大学）第一附属医院核医学科，重庆
- 作者简介：
黄学全，E-mail：huangxq68@tmmu.edu.cn
- 基金信息：重庆市自然科学基金面上项目(CSTB2022NSCQ-MSX1501;CSTB2023NSCQ-MSX0600)
DOI：10.16016/j.2097-0927.202411028
中图分类号： R730.55;R735.7;R817.8收稿日期：2024-11-06，
修回日期：2024-11-22，
纸质出版日期：2025-03-30
- 稿件说明：
移动端阅览
王琛禹，吴治州，刘丽，等.AKT1介导的肝癌细胞自噬增强125I粒籽辐照敏感性［J］.陆军军医大学学报，2025，47（06）：539-550.DOI：10.16016/j.2097-0927.202411028.
WANG C Y，WU Z Z，LIU l，et al.AKT1-mediated autophagy of hepatocellular carcinoma cells enhances cell sensitivity to 125I seed irradiation［J］.J Army Med Univ，2025，47（06）：539-550.DOI：10.16016/j.2097-0927.202411028.
王琛禹，吴治州，刘丽，等.AKT1介导的肝癌细胞自噬增强125I粒籽辐照敏感性［J］.陆军军医大学学报，2025，47（06）：539-550.DOI：10.16016/j.2097-0927.202411028. DOI：
WANG C Y，WU Z Z，LIU l，et al.AKT1-mediated autophagy of hepatocellular carcinoma cells enhances cell sensitivity to 125I seed irradiation［J］.J Army Med Univ，2025，47（06）：539-550.DOI：10.16016/j.2097-0927.202411028. DOI：
摘要
目的
2
探究丝氨酸/苏氨酸蛋白激酶1（serine/threonine-protein kinase 1，AKT1）介导的肝癌细胞自噬对
125
I粒籽辐照敏感性的影响。
方法
2
①利用iProX数据库和STRING12.0网站对
125
I粒籽辐照前后肝癌蛋白组数据进行分析，探究差异表达蛋白及相关功能联系，同时借助癌症基因组图谱（the cancer genome attas， TCGA）数据库分析AKT1表达水平与肝癌患者生存期关系。②利用人肝癌细胞系HUH7和Hep3B构建体外辐照模型，
125
I组细胞接受起始表观活度0.8 mCi/粒籽的
125
I放射性粒籽持续辐照约120 h累计辐射剂量8 Gy，对照组（NC组）正常培养120 h。③使用自噬抑制剂氯喹（chloroquine， CQ）、诱导剂分别处理肝癌细胞系，构建CQ组和RAPA组。运用慢病毒转染技术构建过表达AKT1肝癌细胞系，即AKT1组。将同样处理的肝癌细胞系持续
125
I粒籽辐照120 h，获得CQ+
125
I组、RAPA+
125
I组、AKT1+
125
I组。④Western blot检测微管相关蛋白轻链3（microtubule-associated protein light chain 3，LC3）、p62、AKT1、p-AKT1的变化，利用细胞免疫荧光观察LC3表达；平板克隆实验和流式细胞术实验检测细胞克隆能力以及凋亡率。
结果
2
①
125
I粒籽辐照后，相较于NC组，
125
I组的中p62表达降低（
P
<
0.05），LC3Ⅱ/LC3Ⅰ比值增高（
P
<
0.05），免疫荧光显示LC3绿色荧光点增多。与
125
I组比较，CQ+
125
I组p62表达增高（
P
<
0.01），LC3Ⅱ/LC3Ⅰ比值降低（
P
<
0.01）。在细胞凋亡和克隆能力方面，CQ+
125
I组凋亡率较
125
I组降低（
P
<
0.01），CQ+
125
I组克隆形成数较
125
I组增多（
P
<
0.01），而RAPA+
125
I组结果与之相反。②iProX数据库分析显示，AKT1在辐照组降低，TCGA数据库分析表明，AKT1高表达预示肝癌患
者较差预后（
P
<
0.01）。③
125
I粒籽辐照后，
125
I组AKT1在RNA和蛋白水平表达均降低（
P
<
0.01）。过表达AKT1后，自噬水平降低（
P
<
0.05），
125
I粒籽辐照过表达AKT1的肝癌细胞可部分恢复自噬水平。相较于AKT1组，AKT1+
125
I组的AKT1、p-AKT1、p62表达均降低（
P
<
0.05），LC3Ⅱ/LC3Ⅰ比值增高（
P
<
0.05）。④关于细胞凋亡和克隆能力，AKT1+
125
I组较
125
I组凋亡率降低（
P
<
0.05），AKT1+
125
I组较AKT1组凋亡率升高（
P
<
0.05）。HUH7细胞中AKT1+
125
I组较
125
I组克隆能力提高（
P
<
0.05），在Hep3B细胞中AKT1+
125
I组较
125
I组克隆能力提高（
P
<
0.05），AKT1组较NC组克隆能力增高（
P
<
0.05）。
结论
2
125
I粒籽辐照后的肝癌细胞通过降低AKT1的表达诱导致命性自噬，为
125
I放射性粒籽植入治疗肝癌提供了新的理论依据。
Abstract
Objective To investigate the impact of serine/threonine-protein kinase 1(AKT1)-mediated autophagy in hepatocellular carcinoma (HCC) cells on their sensitivity to
125
I seed irradiation. Methods ① iProX database and STRING12.0 website were utilized to analyze the proteomic data of HCC before and after
125
I seed irradiation to explore the differentially expressed proteins and associated functional connections. Meanwhile
The Cancer Genomics Atlas (TCGA) database was employed to analyze the relationship between AKT1 expression level and the survival of HCC patients. ② Human HCC cell lines HUH7 and Hep3B were exposed to continuous irradiation from
125
I radioactive seeds with an initial apparent activity of 0.8 mCi per seed for approximately 120 h
accumulating a total dose of 8 Gy
while the control cells were cultured under normal condition for 120 h. ③ Autophagy inhibitor
chloroquine (CQ) and inducer
rapamycin (RAPA) were used to treat the HCC cells respectively to establish the CQ group and the RAPA group. The lentiviral transfection technique was employed to construct the HCC cells with overexpressed AKT1
namely the
AKT1 group. The HCC cells treated in the same way were continuously irradiated with
125
I seeds for 120 h to construct the CQ+
125
I group
the RAPA+
125
I group
and the AKT1+
125
I group. ④The changes in microtubule-associated protein light chain 3 (LC3)
p62
AKT1 and p-AKT1 were detected by Western blotting. Cell immunofluorescence assay was employed to observe the expression of autophagy related proteins
such as LC3. The colony forming ability and apoptotic rate were detected with plate cloning assay and flow cytometry. Results ① Continuous irradiation with
125
I seeds resulted in decreased expression of p62 and increased ratio of LC3Ⅱ/LC3Ⅰ (
P
<
0.05) when compared with the negative control (NC) group. Immunofluorescence assay revealed more green fluorescence spots of LC3. When compared with the
125
I group
the CQ +
125
I group had significantly increased expression of p62 (
P
<
0.01)
decreased ratio of LC3Ⅱ/LC3Ⅰ(
P
<
0.01)
lower apoptotic rate (
P
<
0.01)
and more colony formations (
P
<
0.01). In contrast
the results in the RAPA +
125
I group were opposite to those of the CQ +
125
I group. ② Analysis on the iProX database showed that the expression of AKT1 was decreased in the irradiated group
and analysis on the TCGA database indicated that high expression of AKT1 predicted a poor prognosis for HCC patients (
P
<
0.01). ③After irradiation with
125
I seeds
the expression of AKT1 at both the RNA and protein levels was decreased in the
125
I group (
P
<
0.01). After overexpression of AKT1
the level of autophagy was decreased (
P
<
0.05). Irradiation of HCC cells with overexpressed AKT1 using
125
I seeds could partially restore the level of autophagy. In the AKT1 +
125
I group
the expression of AKT1
pAKT1 and p62 were all decreased
and
the ratio of LC3Ⅱ/LC3Ⅰ was increased than the AKT1 group (
P
<
0.05). ④ The apoptotic rate of the AKT1 +
125
I group was lower than that of the
125
I group (
P
<
0.05) and higher than that in the AKT1 group
(P
<
0.05). In HUH7 cells
the clonogenic ability of the AKT1 +
125
I group was higher than that of the
125
I group (
P
<
0.05). In Hep3B cells
the clonogenic ability of the AKT1 +
125
I group was higher than that of the
125
I group
and the clonogenic ability of the AKT1 group was higher than that of the NC group (
P
<
0.05). Conclusion
125
I seed irradiation induce lethal autophagy in HCC cells by reducing the expression of AKT1
providing a new theoretical basis for the implantation of
125
I radioactive seeds in the treatment of HCC.
关键词
Keywords
references
LIU D M ， SONG T Q . Changes in and challenges regarding the surgical treatment of hepatocellular carcinoma in China ［J］. Biosci Trends ， 2021 ， 15 （ 3 ）： 142 - 147 . DOI： 10.5582/bst.2021.01083 http://dx.doi.org/10.5582/bst.2021.01083 .
SUNG H ， FERLAY J ， SIEGEL R L ， et al . Global cancer statistics 2020： GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries ［J］. CA Cancer J Clin ， 2021 ， 71 （ 3 ）： 209 - 249 . DOI： 10.3322/caac.21660 http://dx.doi.org/10.3322/caac.21660 .
ZHU Z X ， HUANG J W ， LIAO M H ， et al . Treatment strategy for hepatocellular carcinoma in China： radiofrequency ablation versus liver resection ［J］. Jpn J Clin Oncol ， 2016 ， 46 （ 12 ）： 1075 - 1080 . DOI： 10.1093/jjco/hyw134 http://dx.doi.org/10.1093/jjco/hyw134 .
CHEN L ， YING X H ， ZHANG D K ， et al . Iodine-125 brachytherapy can prolong progression-free survival of patients with locoregional recurrence and/or residual hepatocellular carcinoma after radiofrequency ablation ［J］. Cancer Biother Radiopharm ， 2021 ， 36 （ 10 ）： 820 - 826 . DOI： 10.1089/cbr.2020.3647 http://dx.doi.org/10.1089/cbr.2020.3647 .
LI Q C ， LIANG Y ， ZHAO Y ， et al . Interpretation of adverse reactions and complications in Chinese expert consensus of iodine-125 brachytherapy for pancreatic cancer ［J］. J Cancer Res Ther ， 2019 ， 15 （ 4 ）： 751 - 754 . DOI： 10.4103/jcrt.JCRT_884_18 http://dx.doi.org/10.4103/jcrt.JCRT_884_18 .
REBOLLO AGUIRRE A C ， FERNÁNDEZ FERNÁNDEZ J ， SÁNCHEZ R S ， et al . Radioguided surgery with iodine-125 seeds in breast cancer patients treated with neoadjuvant chemotherapy ［J］. Rev Esp Med Nucl Imagen Mol ， 2022 ， 41 （ 2 ）： 71 - 77 . DOI： 10.1016/j.remnie.2021.04.017 http://dx.doi.org/10.1016/j.remnie.2021.04.017 .
HOXHAJ G ， MANNING B D . The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism ［J］. Nat Rev Cancer ， 2020 ， 20 ： 74 - 88 . DOI： 10.1038/s41568-019-0216-7 http://dx.doi.org/10.1038/s41568-019-0216-7 .
YANG M ， LIU H ， QIU G P ， et al . Silencing Akt1 enhances the resistance of prostate cancer cells to starvation and inhibits starvation-induced lung metastasis through epithelial-mesenchymal transition in prostate cancer ［J］. Med Oncol ， 2021 ， 39 （ 1 ）： 8 . DOI： 10.1007/s12032-021-01600-z http://dx.doi.org/10.1007/s12032-021-01600-z .
HU W H ， XIE N N ， PAN M M ， et al . Chinese herbal medicine alleviates autophagy and apoptosis in ovarian granulosa cells induced by testosterone through PI3K/AKT1/FOXO1 pathway ［J］. J Ethnopharmacol ， 2024 ， 318 （ Pt B ）： 117025 . DOI： 10.1016/j.jep.2023.117025 http://dx.doi.org/10.1016/j.jep.2023.117025 .
YANG C S ， XIAO Y H ， DU Y X ， et al . Iodine-125 seeds inhibit carcinogenesis of hepatocellular carcinoma cells by suppressing epithelial-mesenchymal transition via TGF- β 1/smad signaling ［J］. Dis Markers ， 2022 ， 2022 ： 9230647 . DOI： 10.1155/2022/9230647 http://dx.doi.org/10.1155/2022/9230647 .
ZHANG W ， DENG R Y ， CHEN B Y ， et al . Safety and efficacy of CT-guided central venous catheter gastric insufflation in percutaneous gastrostomy ［J］. Biomed Res Int ， 2022 ， 2022 ： 9421738 . DOI： 10.1155/2022/9421738 http://dx.doi.org/10.1155/2022/9421738 .
ZHU Z X ， WANG X X ， YUAN K F ， et al . Transarterial chemoembolization plus iodine-125 implantation for hepatocellular carcinoma： a systematic review and meta-analysis ［J］. HPB ， 2018 ， 20 （ 9 ）： 795 - 802 . DOI： 10.1016/j.hpb.2018.03.015 http://dx.doi.org/10.1016/j.hpb.2018.03.015
中华人民共和国国家卫生健康委员会医政司 . 原发性肝癌诊疗指南（2024年版） ［J］. 中华肝脏病杂志 ， 2024 ， 32 （ 7 ）： 581 - 630 . DOI： 10.3760/cma.j.cn501113-20240611-00290 http://dx.doi.org/10.3760/cma.j.cn501113-20240611-00290 .
Guideline for diagnosis and treatment of primary liver cancer （ 2024 version） ［J］. Chin J Hepatol ， 2024， 32 （ 7 ）： 581 - 630 . DOI： 10.3760/cma.j.cn501113-20240611-00290 http://dx.doi.org/10.3760/cma.j.cn501113-20240611-00290
ZHANG J ， XIANG Q ， WU M ， et al . Autophagy regulators in cancer ［J］. Int J Mol Sci ， 2023 ， 24 （ 13 ）： 10944 . DOI： 10.3390/ijms241310944 http://dx.doi.org/10.3390/ijms241310944 ..
SUN H W ， ZHU R Y ， GUO X J ， et al . Exosome miR-101-3p derived from bone marrow mesenchymal stem cells promotes radiotherapy sensitivity in non-small cell lung cancer by regulating DNA damage repair and autophagy levels through EZH2 ［J］. Pathol Res Pract ， 2024 ， 256 ： 155271 . DOI： 10.1016/j.prp.2024.155271 http://dx.doi.org/10.1016/j.prp.2024.155271 .
WANG Y H ， CHEN B C ， XIAO M ， et al . Brucea javanica oil emulsion promotes autophagy in ovarian cancer cells through the miR-8485/LAMTOR3/mTOR/ATG13 signaling axis ［J］. Front Pharmacol ， 2022 ， 13 ： 935155 . DOI： 10.3389/fphar.2022.935155 http://dx.doi.org/10.3389/fphar.2022.935155 .
MIRZA Z ， KARIM S . Structure-based profiling of potential phytomolecules with AKT1 a key cancer drug target ［J］. Molecules ， 2023 ， 28 （ 6 ）： 2597 . DOI： 10.3390/molecules 28062597 http://dx.doi.org/10.3390/molecules28062597 .
DING L ， JIANG H ， LI Q W ， et al . Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer ［J］. J Exp Clin Cancer Res ， 2024 ， 43 （ 1 ）： 90 . DOI： 10.1186/s13046-024-03016-9 http://dx.doi.org/10.1186/s13046-024-03016-9 .
ZHANG X ， WANG S ， WANG H X ， et al . Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway ［J］. Mol Cancer ， 2019 ， 18 （ 1 ）： 20 . DOI： 10.1186/s12943-018-0935-5 http://dx.doi.org/10.1186/s12943-018-0935-5 .
SMYTH L M ， TAMURA K ， OLIVEIRA M ， et al . Capivasertib， an AKT kinase inhibitor， as monotherapy or in combination with fulvestrant in patients with AKT1 E17K -mutant， ER-positive metastatic breast cancer ［J］. Clin Cancer Res ， 2020 ， 26 （ 15 ）： 3947 - 3957 . DOI： 10.1158/1078-0432.CCR-19-3953 http://dx.doi.org/10.1158/1078-0432.CCR-19-3953 .
TURNER N ， DENT R A ， O’SHAUGHNESSY J ， et al . Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer： primary results from cohort B of the IPATunity130 randomized phase 3 trial ［J］. Breast Cancer Res Treat ， 2022 ， 191 （ 3 ）： 565 - 576 . DOI： 10.1007/s10549-021-06450-x http://dx.doi.org/10.1007/s10549-021-06450-x .
YU M ， ZENG M H ， PAN Z P ， et al . Discovery of novel Akt1 inhibitor induces autophagy associated death in hepatocellular carcinoma cells ［J］. Eur J Med Chem ， 2020 ， 189 ： 112076 . DOI： 10.1016/j.ejmech.2020.112076 http://dx.doi.org/10.1016/j.ejmech.2020.112076 .
SHI Z K ， YUAN H ， CAO L Q ， et al . AKT1 participates in ferroptosis vulnerability by driving autophagic degradation of FTH1 in cisplatin-resistant ovarian cancer ［J］. Biochem Cell Biol ， 2023 ， 101 （ 5 ）： 422 - 431 . DOI： 10.1139/bcb-2022-0361 http://dx.doi.org/10.1139/bcb-2022-0361 .
0
浏览量
0
下载量
0
CSCD
- 网络PDF下载
- WORD下载
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
